Wadden, PhDand funded by Novo Nordisk, the maker of semaglutidefound that GLP-1 users without known psychopathology werent any more likely to develop depression or suicidal thoughts or actions than controls
"Each person responds differently to medications, and the degree of weight loss achieved with treatment can vary based on personal factors," Priya Jaisinghani, MD, a clinical assistant professor at the NYU Grossman School of Medicine, told Health
Many of these improvements are likely related to better mobility, exercise endurance, and cardiovascular conditioning
Top opportunities for retailers include: Placing dietary and supplement products near pharmacies Enhancing digital commerce platforms to support personalized filtering Highlighting weight-loss-friendly attributes on packaged goods Creating educational tools within retailer apps Over 90% of Millennials and Gen Z express interest in packaged foods that support their goals, so clear labeling and nutrient-focused offerings will play a key role in future loyalty
